Mechanisms of liver disease in AATD

Pasquale Piccolo, Sergio Attanasio, Nicola Brunetti-Pierri

Source: Eur Respir Monogr 2019; 85: 93-104
Journal Issue: a1-Antitrypsin Deficiency
Disease area: Respiratory infections

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pasquale Piccolo, Sergio Attanasio, Nicola Brunetti-Pierri. Mechanisms of liver disease in AATD. Eur Respir Monogr 2019; 85: 93-104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mechanisms of lung disease in AATD
Source: Eur Respir Monogr 2019; 85: 52-63
Year: 2019


Clinical approach to liver disease in adults with AATD
Source: Eur Respir Monogr 2019; 85: 114-126
Year: 2019


Treatment of lung disease in patients with AATD
Source: Eur Respir Monogr 2019; 85: 78-92
Year: 2019


Screening of chronic liver disease by transient elastography in patients with lung disease associated with alpha-1 antitrypsin deficiency.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018


Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

Alpha-1-antitrypsin deficiency
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139
Year: 2005

Study of lung functions in patients of chronic liver disease.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017


Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Mitochondrial dysfunction in chronic lung disease
Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease
Year: 2016


Osteoporosis in end-stage lung disease
Source: Eur Respir Mon; 2009: 45: 62–78
Year: 2009

Lung involvement in autoimmune liver diseases
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019


Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016


The role of vascular endothelial growth factor D in diagnosis of polycystic lung diseases
Source: Annual Congress 2013 –Clinical management of orphan lung diseases
Year: 2013

Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Year: 2020



Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Year: 2020



Translational immunology in genetic lung disease: advances in cystic fibrosis and Alpha-1 anti-trypsin deficiency
Source: International Congress 2014 – From bench to bronchiole: translational immunology and airways disease
Year: 2014